Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells

Ian H Batty, Ian Neil Fleming, C Peter Downes

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In 1321N1 astrocytoma cells, stimulation of the IGF-1 (insulin-like growth factor-1) receptor increased the association of PI3K [phosphoinositide (PI) 3-kinase] activity with IRS-1 (insulin re-ceptor substrate 1), and increased the cellular concentration of PtdIns(3,4,5)P3. Carbachol, acting on M3 muscarinic receptors, inhibited insulin-, but not PDGF (platelet-derived growth factor)-, stimulated responses by approximately 50%. The inhibition of IRS-1-associated PI3K activity by carbachol (i) was rapid ( or =60 min) and potent (half-maximal concentration approximately 1 microM); (ii) was reproduced by stimuli for several phospholipase-C-coupled receptors; (iii) was prevented by the inhibition of protein kinase C, but not by chelation of intracellular Ca2+; and (iv) was not blocked or reproduced by inhibitors or stimuli respectively of mitogen-activated protein kinase, PI3K, protein kinase B or the mammalian target of rapamycin. However, the effects of carbachol were prevented by sodium vanadate, a protein tyrosine phosphatase inhibitor, and were accompanied by reduced insulin-stimulated IRS-1 tyrosine phosphorylation and recruitment of the 85 kDa regulatory subunit of PI3K to IRS-1, but not by reduced IGF-1 receptor kinase activity. The inhibitory effect of carbachol was reproduced by okadaic acid, a protein serine/threonine phosphatase inhibitor, but not by PDGF, yet all three agents stimulated the serine phosphorylation of IRS-1 at residues Ser312, Ser616 and Ser636/639, albeit to different extents. Thus muscarinic receptors may inhibit insulin signalling by promoting IRS-1 tyrosine dephosphorylation and/or by uncoupling IRS-1 from the stimulated IGF-1 receptor by stimulating IRS-1 serine phosphorylation. However, the proportion of IRS-1 molecules phosphorylated at a particular site or the phosphorylation of additional IRS-1 serine residues other than those noted above must be important.
Original languageEnglish
Pages (from-to)641-651
Number of pages11
JournalBiochemical Journal
Volume379
Issue number3
DOIs
Publication statusPublished - 1 May 2004

Fingerprint

Somatomedin Receptors
1-Phosphatidylinositol 4-Kinase
Astrocytoma
Muscarinic Receptors
Somatomedins
Phosphatidylinositols
Phosphotransferases
Insulin
Substrates
Phosphorylation
Carbachol
Phosphatidylinositol 3-Kinases
Serine
Platelet-Derived Growth Factor
Tyrosine
Muscarinic M3 Receptors
Okadaic Acid
Proto-Oncogene Proteins c-akt
Protein Tyrosine Phosphatases
Vanadates

Keywords

  • astrocytoma
  • calcium
  • carbachol
  • tumor cell line
  • enzyme activation
  • humans
  • inositol 1,4,5-trisphosphate
  • insulin
  • insulin receptor substrate proteins
  • Ionomycin
  • mitogen-activated protein kinases
  • okadaic acid
  • phosphatidylinositol 3-kinases
  • phosphoproteins
  • phosphorylation
  • phosphoserine
  • phosphotyrosine
  • platelet-derived growth factor
  • protein kinase C
  • protein-serine-threonine kinases
  • proto-oncogene proteins
  • proto-oncogene proteins c-akt
  • IGF type 1 receptor
  • muscarinic receptors
  • ribosomal protein S6 kinases, 70-kDa
  • signal transduction
  • tetradecanoylphorbol acetate
  • type C phospholipases

Cite this

Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells. / Batty, Ian H; Fleming, Ian Neil; Downes, C Peter.

In: Biochemical Journal, Vol. 379, No. 3, 01.05.2004, p. 641-651.

Research output: Contribution to journalArticle

@article{3b18aeb3b79e4c138670b32feb87652f,
title = "Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells",
abstract = "In 1321N1 astrocytoma cells, stimulation of the IGF-1 (insulin-like growth factor-1) receptor increased the association of PI3K [phosphoinositide (PI) 3-kinase] activity with IRS-1 (insulin re-ceptor substrate 1), and increased the cellular concentration of PtdIns(3,4,5)P3. Carbachol, acting on M3 muscarinic receptors, inhibited insulin-, but not PDGF (platelet-derived growth factor)-, stimulated responses by approximately 50{\%}. The inhibition of IRS-1-associated PI3K activity by carbachol (i) was rapid ( or =60 min) and potent (half-maximal concentration approximately 1 microM); (ii) was reproduced by stimuli for several phospholipase-C-coupled receptors; (iii) was prevented by the inhibition of protein kinase C, but not by chelation of intracellular Ca2+; and (iv) was not blocked or reproduced by inhibitors or stimuli respectively of mitogen-activated protein kinase, PI3K, protein kinase B or the mammalian target of rapamycin. However, the effects of carbachol were prevented by sodium vanadate, a protein tyrosine phosphatase inhibitor, and were accompanied by reduced insulin-stimulated IRS-1 tyrosine phosphorylation and recruitment of the 85 kDa regulatory subunit of PI3K to IRS-1, but not by reduced IGF-1 receptor kinase activity. The inhibitory effect of carbachol was reproduced by okadaic acid, a protein serine/threonine phosphatase inhibitor, but not by PDGF, yet all three agents stimulated the serine phosphorylation of IRS-1 at residues Ser312, Ser616 and Ser636/639, albeit to different extents. Thus muscarinic receptors may inhibit insulin signalling by promoting IRS-1 tyrosine dephosphorylation and/or by uncoupling IRS-1 from the stimulated IGF-1 receptor by stimulating IRS-1 serine phosphorylation. However, the proportion of IRS-1 molecules phosphorylated at a particular site or the phosphorylation of additional IRS-1 serine residues other than those noted above must be important.",
keywords = "astrocytoma, calcium, carbachol, tumor cell line, enzyme activation, humans, inositol 1,4,5-trisphosphate, insulin, insulin receptor substrate proteins, Ionomycin, mitogen-activated protein kinases, okadaic acid, phosphatidylinositol 3-kinases, phosphoproteins, phosphorylation, phosphoserine, phosphotyrosine, platelet-derived growth factor, protein kinase C, protein-serine-threonine kinases, proto-oncogene proteins, proto-oncogene proteins c-akt, IGF type 1 receptor, muscarinic receptors, ribosomal protein S6 kinases, 70-kDa, signal transduction, tetradecanoylphorbol acetate, type C phospholipases",
author = "Batty, {Ian H} and Fleming, {Ian Neil} and Downes, {C Peter}",
year = "2004",
month = "5",
day = "1",
doi = "10.1042/BJ20031700",
language = "English",
volume = "379",
pages = "641--651",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells

AU - Batty, Ian H

AU - Fleming, Ian Neil

AU - Downes, C Peter

PY - 2004/5/1

Y1 - 2004/5/1

N2 - In 1321N1 astrocytoma cells, stimulation of the IGF-1 (insulin-like growth factor-1) receptor increased the association of PI3K [phosphoinositide (PI) 3-kinase] activity with IRS-1 (insulin re-ceptor substrate 1), and increased the cellular concentration of PtdIns(3,4,5)P3. Carbachol, acting on M3 muscarinic receptors, inhibited insulin-, but not PDGF (platelet-derived growth factor)-, stimulated responses by approximately 50%. The inhibition of IRS-1-associated PI3K activity by carbachol (i) was rapid ( or =60 min) and potent (half-maximal concentration approximately 1 microM); (ii) was reproduced by stimuli for several phospholipase-C-coupled receptors; (iii) was prevented by the inhibition of protein kinase C, but not by chelation of intracellular Ca2+; and (iv) was not blocked or reproduced by inhibitors or stimuli respectively of mitogen-activated protein kinase, PI3K, protein kinase B or the mammalian target of rapamycin. However, the effects of carbachol were prevented by sodium vanadate, a protein tyrosine phosphatase inhibitor, and were accompanied by reduced insulin-stimulated IRS-1 tyrosine phosphorylation and recruitment of the 85 kDa regulatory subunit of PI3K to IRS-1, but not by reduced IGF-1 receptor kinase activity. The inhibitory effect of carbachol was reproduced by okadaic acid, a protein serine/threonine phosphatase inhibitor, but not by PDGF, yet all three agents stimulated the serine phosphorylation of IRS-1 at residues Ser312, Ser616 and Ser636/639, albeit to different extents. Thus muscarinic receptors may inhibit insulin signalling by promoting IRS-1 tyrosine dephosphorylation and/or by uncoupling IRS-1 from the stimulated IGF-1 receptor by stimulating IRS-1 serine phosphorylation. However, the proportion of IRS-1 molecules phosphorylated at a particular site or the phosphorylation of additional IRS-1 serine residues other than those noted above must be important.

AB - In 1321N1 astrocytoma cells, stimulation of the IGF-1 (insulin-like growth factor-1) receptor increased the association of PI3K [phosphoinositide (PI) 3-kinase] activity with IRS-1 (insulin re-ceptor substrate 1), and increased the cellular concentration of PtdIns(3,4,5)P3. Carbachol, acting on M3 muscarinic receptors, inhibited insulin-, but not PDGF (platelet-derived growth factor)-, stimulated responses by approximately 50%. The inhibition of IRS-1-associated PI3K activity by carbachol (i) was rapid ( or =60 min) and potent (half-maximal concentration approximately 1 microM); (ii) was reproduced by stimuli for several phospholipase-C-coupled receptors; (iii) was prevented by the inhibition of protein kinase C, but not by chelation of intracellular Ca2+; and (iv) was not blocked or reproduced by inhibitors or stimuli respectively of mitogen-activated protein kinase, PI3K, protein kinase B or the mammalian target of rapamycin. However, the effects of carbachol were prevented by sodium vanadate, a protein tyrosine phosphatase inhibitor, and were accompanied by reduced insulin-stimulated IRS-1 tyrosine phosphorylation and recruitment of the 85 kDa regulatory subunit of PI3K to IRS-1, but not by reduced IGF-1 receptor kinase activity. The inhibitory effect of carbachol was reproduced by okadaic acid, a protein serine/threonine phosphatase inhibitor, but not by PDGF, yet all three agents stimulated the serine phosphorylation of IRS-1 at residues Ser312, Ser616 and Ser636/639, albeit to different extents. Thus muscarinic receptors may inhibit insulin signalling by promoting IRS-1 tyrosine dephosphorylation and/or by uncoupling IRS-1 from the stimulated IGF-1 receptor by stimulating IRS-1 serine phosphorylation. However, the proportion of IRS-1 molecules phosphorylated at a particular site or the phosphorylation of additional IRS-1 serine residues other than those noted above must be important.

KW - astrocytoma

KW - calcium

KW - carbachol

KW - tumor cell line

KW - enzyme activation

KW - humans

KW - inositol 1,4,5-trisphosphate

KW - insulin

KW - insulin receptor substrate proteins

KW - Ionomycin

KW - mitogen-activated protein kinases

KW - okadaic acid

KW - phosphatidylinositol 3-kinases

KW - phosphoproteins

KW - phosphorylation

KW - phosphoserine

KW - phosphotyrosine

KW - platelet-derived growth factor

KW - protein kinase C

KW - protein-serine-threonine kinases

KW - proto-oncogene proteins

KW - proto-oncogene proteins c-akt

KW - IGF type 1 receptor

KW - muscarinic receptors

KW - ribosomal protein S6 kinases, 70-kDa

KW - signal transduction

KW - tetradecanoylphorbol acetate

KW - type C phospholipases

U2 - 10.1042/BJ20031700

DO - 10.1042/BJ20031700

M3 - Article

VL - 379

SP - 641

EP - 651

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -